Cigna Group $CI Shares Acquired by Rakuten Investment Management Inc.

Rakuten Investment Management Inc. increased its position in Cigna Group (NYSE:CIFree Report) by 16.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,131 shares of the health services provider’s stock after buying an additional 4,955 shares during the quarter. Rakuten Investment Management Inc.’s holdings in Cigna Group were worth $9,697,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of CI. Brighton Jones LLC lifted its holdings in shares of Cigna Group by 9.3% in the fourth quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider’s stock valued at $1,032,000 after buying an additional 318 shares during the period. Sivia Capital Partners LLC lifted its holdings in shares of Cigna Group by 10.4% during the second quarter. Sivia Capital Partners LLC now owns 1,160 shares of the health services provider’s stock valued at $384,000 after purchasing an additional 109 shares during the last quarter. NewEdge Advisors LLC lifted its holdings in shares of Cigna Group by 4.5% during the second quarter. NewEdge Advisors LLC now owns 22,225 shares of the health services provider’s stock valued at $7,347,000 after purchasing an additional 958 shares during the last quarter. Treasurer of the State of North Carolina lifted its holdings in shares of Cigna Group by 16.6% during the second quarter. Treasurer of the State of North Carolina now owns 148,840 shares of the health services provider’s stock valued at $49,204,000 after purchasing an additional 21,173 shares during the last quarter. Finally, Osterweis Capital Management Inc. purchased a new stake in shares of Cigna Group during the second quarter valued at $163,000. Institutional investors and hedge funds own 86.99% of the company’s stock.

Cigna Group Stock Down 0.6%

Shares of Cigna Group stock opened at $292.01 on Wednesday. The stock has a 50-day moving average price of $283.44 and a 200 day moving average price of $278.26. The company has a market cap of $77.25 billion, a P/E ratio of 12.38, a P/E/G ratio of 1.13 and a beta of 0.28. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 1 year low of $239.51 and a 1 year high of $338.89.

Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.60 by $0.19. The firm had revenue of $68.52 billion during the quarter, compared to the consensus estimate of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period in the prior year, the business earned $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts expect that Cigna Group will post 30.39 EPS for the current fiscal year.

Cigna Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 annualized dividend and a yield of 2.1%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio is currently 26.45%.

Insider Activity

In related news, CAO Jamie G. Kates sold 899 shares of the stock in a transaction dated Friday, June 12th. The stock was sold at an average price of $298.61, for a total value of $268,450.39. Following the completion of the sale, the chief accounting officer directly owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. This represents a 27.52% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO David Cordani sold 201,878 shares of the stock in a transaction dated Tuesday, May 12th. The stock was sold at an average price of $292.82, for a total value of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at approximately $10,054,560.34. This represents a 85.46% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on CI shares. Morgan Stanley upped their target price on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Raymond James Financial set a $340.00 target price on Cigna Group in a report on Friday, May 1st. UBS Group upped their target price on Cigna Group from $375.00 to $400.00 and gave the company a “buy” rating in a report on Friday, May 22nd. Deutsche Bank Aktiengesellschaft downgraded Cigna Group from a “buy” rating to a “hold” rating and reduced their target price for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Finally, Barclays downgraded Cigna Group from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $310.00 to $304.00 in a report on Tuesday, May 26th. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $338.30.

View Our Latest Stock Analysis on Cigna Group

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

See Also

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.